Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

East-West Hepatocellular Carcinoma Study Group

This study has been completed.
Information provided by:
University of Milan Identifier:
First received: November 8, 2010
Last updated: NA
Last verified: December 2009
History: No changes posted

The current treatment guidelines of hepatocellular carcinoma (HCC) of the American and European Associations for the Study of Liver Disease are based on the Barcelona-Clinic-Liver-Cancer classification (BCLC), which does not recommend surgery in patients with large, multinodular and macrovascular invasive disease. The aim of this study was to investigate the role of hepatic resection in a large retrospective multicentric cohort of patients resected for HCC regardless of the BCLC indications.

Carcinoma, Hepatocellular

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective

Resource links provided by NLM:

Further study details as provided by University of Milan:

Primary Outcome Measures:
  • Overall survival of resected patients for HCC
    The primary endpoint of the study was the overall survival of patients resected for HCC in any stage of the BCLC classification.

Secondary Outcome Measures:
  • Disease-free survival of resected patients for HCC
    The secondary endpoint was the disease-free survival of patients resected for HCC among the BCLC stages.


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients affected by HCC


Inclusion Criteria:

  • clinical diagnosis of hepatocellular carcinoma
  • candidate to liver resection as a curative treatment

Exclusion Criteria:

  • uncertain diagnosis of hepatocellular carcinoma
  • uncertain follow-up data
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: GUIDO TORZILLI MD, PHD, UNIVERSITY OF MILAN Identifier: NCT01237132     History of Changes
Other Study ID Numbers: HCC EWE
Study First Received: November 8, 2010
Last Updated: November 8, 2010
Health Authority: Italy: Health Ministery

Additional relevant MeSH terms:
Carcinoma, Hepatocellular
Digestive System Diseases
Digestive System Neoplasms
Liver Diseases
Liver Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial processed this record on March 03, 2015